Adjuvant cyclophosphamide, methotrexate and fluorouracil for node-positive breast cancer: a lifetime cost-utility analysis based on a modified Q-TWIST method

被引：8
作者：
Trippoli, S [1 ]
Becagli, P [1 ]
Messori, A [1 ]
机构：
[1] Policlin Careggi Hosp, Azienda Osped Careggi, Pharmaceut Serv, Drug Informat Ctr, I-50134 Florence, Italy
来源：
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1997年 / 53卷 / 3-4期
关键词：
breast cancer; survival;
D O I：
10.1007/s002280050378
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：281 / 282
页数：2
相关论文
共 14 条
[1]   CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL IN NODE-POSITIVE BREAST-CANCER - THE RESULTS OF 20 YEARS OF FOLLOW-UP [J].
BONADONNA, G ;
VALAGUSSA, P ;
MOLITERNI, A ;
ZAMBETTI, M ;
BRAMBILLA, C .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (14) :901-906
[2]   QUALITY-OF-LIFE-ADJUSTED EVALUATION OF ADJUVANT THERAPIES FOR OPERABLE BREAST-CANCER [J].
GELBER, RD ;
GOLDHIRSCH, A ;
CAVALLI, F .
ANNALS OF INTERNAL MEDICINE, 1991, 114 (08) :621-628
[3]   Adjuvant chemotherapy plus tamoxifen compared with tamoxifen alone for postmenopausal breast cancer: Meta-analysis of quality-adjusted survival [J].
Gelber, RD ;
Cole, BF ;
Goldhirsch, A ;
Rose, C ;
Fisher, B ;
Osborne, CK ;
Boccardo, F ;
Gray, R ;
Gordon, NH ;
Bengtsson, NO ;
Sevelda, P .
LANCET, 1996, 347 (9008) :1066-1071
[4]   QUALITY-OF-LIFE EVALUATION IN A CLINICAL-TRIAL OF ZIDOVUDINE THERAPY IN PATIENTS WITH MILDLY SYMPTOMATIC HIV-INFECTION [J].
GELBER, RD ;
LENDERKING, WR ;
COTTON, DJ ;
COLE, BF ;
FISCHL, MA ;
GOLDHIRSCH, A ;
TESTA, MA .
ANNALS OF INTERNAL MEDICINE, 1992, 116 (12) :961-966
[5]   A quality-adjusted time without symptoms or toxicity (Q-TWIST) analysis of adjuvant radiation therapy and chemotherapy for resectable rectal cancer [J].
Gelber, RD ;
Goldhirsch, A ;
Cole, BF ;
Wieand, HS ;
Schroeder, G ;
Krook, JE .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (15) :1039-1045
[6]   COST-EFFECTIVENESS OF THROMBOLYTIC THERAPY WITH TISSUE-PLASMINOGEN ACTIVATOR AS COMPARED WITH STREPTOKINASE FOR ACUTE MYOCARDIAL-INFARCTION [J].
MARK, DB ;
HLATKY, MA ;
CALIFF, RM ;
NAYLOR, CD ;
LEE, KL ;
ARMSTRONG, PW ;
BARBASH, G ;
WHITE, H ;
SIMOONS, ML ;
NELSON, CL ;
CLAPPCHANNING, N ;
KNIGHT, JD ;
HARRELL, FE ;
SIMES, J ;
TOPOL, EJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (21) :1418-1424
[7]   Survival curve fitting using the Gompertz function: A methodology for conducting cost-effectiveness analyses on mortality data [J].
Messori, A .
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 1997, 52 (03) :157-164
[8]   A retrospective cost-effectiveness analysis of interferon as adjuvant therapy in high-risk resected cutaneous melanoma [J].
Messori, A ;
Becagli, P ;
Trippoli, S ;
Tendi, E .
EUROPEAN JOURNAL OF CANCER, 1997, 33 (09) :1373-1379
[9]  
Messori A, 1996, CANCER, V78, P2366, DOI 10.1002/(SICI)1097-0142(19961201)78:11<2366::AID-CNCR15>3.0.CO
[10]  
2-Z
12